New nalmefene study could speed up opioid overdose rescue
NCT ID NCT07543276
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested how a new form of nalmefene (a drug that reverses opioid overdoses) behaves in the body when given as a shot or through an IV. 13 healthy adults received single doses of both the new and standard versions. The goal was to see how quickly the drug reaches the bloodstream, which could help make overdose treatments faster and more effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID OVERDOSE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ohio Clinical Trials
Columbus, Ohio, 43212, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Peer-led prevention: can gancheros help stop HIV, hepatitis c, and overdose in NYC?
- ER opioid overdose study pulled before it began
- Can an app save lives from overdose? philly trial aims to find out
- Can a computer predict overdose outbreaks? rhode island trial tests new tool
- New naloxone spray tested for faster overdose help
- ER study sheds light on hidden xylazine in opioid overdoses